Plain-English translation of NCT07172464 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new heart device called the P3 Occluder System, which is designed to close a small opening in the heart called a patent foramen ovale (PFO). The device is being tested in people who have experienced a stroke that doctors believe may be connected to this heart opening. The main goal is to find out whether this new device is safe and effective at closing the opening and reducing the risk of another stroke.
Many people have a small opening in their heart that they're born with, and sometimes this opening may allow blood clots to pass through and cause a stroke. This trial exists to test whether this new treatment can safely close that opening and help prevent future strokes in patients who have already had one.
You likely qualify if…
You likely don't qualify if…
If you qualify and choose to participate, you will undergo a procedure to have the P3 Occluder System implanted in your heart. After the procedure, you will visit your doctor for follow-up exams at 1 month, 3 months, 6 months, 1 year, and 5 years. You will also receive phone calls from the study team at 2, 3, and 4 years after your procedure to answer survey questions. The entire study involvement lasts 5 years.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States